By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    stress management for healthcare workers
    3 Tips For Healthcare Professionals: How To Stay Beautiful, Healthy, and Happy
    November 2, 2021
    importance of relaxing on the weekend for your health
    Importance of Relaxing During the Weekend for Optimal Health
    March 25, 2022
    LASIK Eye Surgery
    What Is LASIK Eye Surgery?
    May 16, 2022
    Latest News
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
    The Hidden Impact Of Stress On Your Body’s Alignment And Balance
    May 22, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    vaccinations
    Vaccines Matter: A Public Health Rant
    February 4, 2015
    Dartmouth: Risk Adjustment Doesn’t Work
    February 22, 2013
    Bacteriophages: A Ray of Hope in the Fight against Antibacterial Resistance?
    September 29, 2015
    Latest News
    Top HIPAA-Compliant Messaging Apps for Healthcare Teams
    June 25, 2025
    When Healthcare Ends, the Legal Process Begins: What Families Should Know About Probate and Medical Estates
    June 20, 2025
    Preventing Contamination In Healthcare Facilities Starts With Hygiene
    June 15, 2025
    Strengthening Healthcare Systems Through Clinical and Administrative Career Development
    June 13, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Rib-X Pharmaceuticals’ Nobel Prize Winning Platform Combats Serious Infections
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > Rib-X Pharmaceuticals’ Nobel Prize Winning Platform Combats Serious Infections
Public Health

Rib-X Pharmaceuticals’ Nobel Prize Winning Platform Combats Serious Infections

HerinaAyot
Last updated: June 9, 2011 2:01 am
HerinaAyot
Share
3 Min Read
SHARE

Rib-X Pharmaceuticals is developing broad spectrum antibiotics with superior coverage, safety and convenience to deliver new standards of care for patients with serious infections.

Rib-X Pharmaceuticals is developing broad spectrum antibiotics with superior coverage, safety and convenience to deliver new standards of care for patients with serious infections. The company’s Nobel Prize winning platform enables a unique understanding of how antibiotics combat infection and has generated an industry leading pipeline spanning all phases of research and clinical development.

In 2006, worldwide sales of all anti-infective drugs totaled approximately $66.5 billion, with sales of antibiotics accounting for approximately 50% of the total. The overall market is expected to continue its growth and the antibiotic market is expected to reach $45 billion by 2012. This growth is due in large part to the increasing emergence of multi-drug resistant bacterial strains, the deficiencies of currently available antibiotics to treat certain serious bacterial infections and a vulnerable aging population throughout the world’s major markets. The costs associated with managing antibiotic resistance in the U.S. have reached an estimated $10 billion per year and continue to escalate.

In January 2011, Rib-X Pharmaceuticals announced that the company raised $20 million to support ongoing development of their pipeline, including late-stage clinical development of delafloxacin, a hospital focused novel antibiotic that offers both IV and oral versatility in the treatment of resistant infections. Delafloxacin recently  entered a Phase 2b study.

More Read

Teens And STDs: 3 Best Practices For Mitigating Risk
Teens And STDs: 3 Best Practices For Mitigating Risk
Coaching Into Care Can Help Vets
7 Common Health Issues Faced by Students
House GOP Brings Obamacare Up to a Vote (Again) This Week
Oral Health: How To Prepare For A Dental Emergency

“2011 will be a transformational year for Rib-X and these funds will directly support a number of key initiatives for the company,” said Mark Leuchtenberger, President and Chief Executive Officer at Rib-X.

The financing was led by current investor Warburg Pincus LLC. “We are pleased to continue to support the Rib-X management team and the Company’s innovative antibiotic pipeline, which targets infections resistant to existing antibiotics,” said Jonathan Leff, Managing Director at Warburg Pincus. “Through its deep expertise in antibiotics and insights in structure-based drug design around the bacterial ribosome, Rib-X has brought two differentiated products into advanced clinical development and has created a novel antibiotic discovery platform with the capability to target even the most resistant Gram-negative infections.”

Rib-X Pharmaceuticals will be presenting their technology at OneMedForum NY 2011.

 

TAGGED:antibioticspublic health
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

women dental care
What Is a Smile Makeover and How Much Does It Cost?
Dental health
June 30, 2025
HIPAA-Compliant Messaging Apps
Top HIPAA-Compliant Messaging Apps for Healthcare Teams
Global Healthcare Policy & Law Technology
June 25, 2025
recovering from injury
Rebuilding After Injury: Path to Physical and Emotional Recovery
News
June 22, 2025
scientist using microscope
When Healthcare Ends, the Legal Process Begins: What Families Should Know About Probate and Medical Estates
Global Healthcare
June 18, 2025

You Might also Like

Has China Done a Good Job Handling H7N9?

May 17, 2013

Rural Health White Paper Released by UnitedHealth Group Think Tank

July 27, 2011
drug discount cards
BusinessPublic Health

Drug Discount Cards: Lifting the Veil of Secrecy

August 28, 2013
doctor guilds
FinanceHealth ReformHospital AdministrationPolicy & LawPublic Health

Do All of Us Really Have to Change?

June 13, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?